Agenda

Friday, March 8, 2019

 Agenda for ISLAA 2019
Session I – LAA Exclusion Anatomy and Imaging

7:45 AM – 7:50 AM

Welcome – Course Directors

7:50 AM – 8:00 AM

Understanding the LAA Anatomy – Relevance to Systemic Thromboembolization and Exclusion Techniques – 

8:00 AM – 8:10 AM

Pre and Intra-procedural TEE Imaging for Effective LAA Exclusion – 

8:10 AM – 8:20 AM

CT Imaging for LAA Exclusion – Pre and Post Procedural Assessment – 

8:20 AM – 8:30 AM

Left Atrial Appendage Role in Atrial Arrhythmia’s Origin and Maintenance

8:30 AM – 8:50 AM

Panel Discussion

Session II – Live Case 1

8:50  AM – 9:30 AM

Live Case – 

9:30 AM – 9:40 AM

Mechanism, Predictors and Differences in LAA Leaks Post Attempted Occlusion

9:40 AM – 9:50 AM

Evolution of Leaks Post Implant – When Do you Reassess and Why?

9:50 AM – 10:00 AM

Implications of Leaks on Systemic Thromboembolism and Long-Term OAC/APT After LAA Occlusion

10:00 AM – 10:10 AM

Management of Endocardial Occluder Leaks

10:10 AM – 10:20 AM

Management of Epicardial Exclusion Device Leaks

10:20 AM – 10:30 AM

Panel Discussion

10:30 AM – 10:45 AM

Break

Session III – Live Case 2

10:45 AM – 10:55 AM

Tips and Tricks for Safe Epicardial Access – Micropuncture, EPiEP and More 

10:55 AM – 11:30 PM

Live Case – 

11:30 PM – 11:40 PM

Managing Post Procedural Pericardial Drain and Pericarditis – Colchicine, Steroids, Liposomal Bupivacaine and More

11:40 PM – 11:50 PM

How to Manage A Cardiac Perforation During LAA Closure Device Placement?

11:50 PM- 12:15 PM

Panel Discussion

12:15 PM- 1:00 PM

Lunch

Session IV – 

1:00 PM – 1:10 PM

Tips and Tricks for Safe Trans-septal Puncture and Device Manipulation – 

1:10 PM – 1:50 PM

Live Case – 

1:50 PM – 2:00 PM

How to Prevent and Manage Device Embolization

2:00 PM – 2:10 PM

ICE VS. TEE Intra-Procedurally When and Why?

2:10 PM  – 2:20 PM

Device Related Thrombus – Incidence, Mechanism and Implications to STE

2:20 PM  – 2:30 PM

How to Manage DRT in Patients OAC Tolerant and Intolerant

2:300 PM  – 2:40 PM

How to Prevent LAAO Device Embolization

2:40 PM  – 2:50 PM

How to Manage LAAO Device Embolization

2:50 PM  – 3:10 PM

Panel Discussion

Session V – 

3:100 PM – 3:20 PM

LAA Reservoir Function and Impact of Exclusion Versus Occlusion

3:20 PM – 3:30 PM

Impact of LAA Exclusion – ANP, RAAS, and LAA Homeostasis

3:30 PM – 3:50 PM

Break

3:50 PM – 4:30 PM

Live  Case –

4:30 PM – 4:40 PM

Impact of LAA Exclusion – ANP, RAAS, and LAA Homeostasis

4:30 – 4:40

LAA Exclusion in Arrhythmia Treatment – LAALA AF, aMAZE and More 

4:40 – 4:50

LAA Exclusion vs Renal Denervation for Hypertension – What Does the FUture Hold?

4:50 – 5:00

WATCHMAN vs WATCHMAN Flex

5:00 – 5:30

Panel Discussion

 

Adjourn

Saturday, March 9, 2019

 
 
 
Session VII  – 

8:00 AM – 8:20 AM

Same Day LAAO and TAVR – (WATCHMAN-TAVR Study and More)

8:20 AM  – 8:30 AM

Managing Post Procedural Anticoagulation and Antiplatelet Treatment – Differences Between Devices and Patient Substrates – 

8:30 AM  – 8:40 AM

Understanding  Leaks, Pulmonary Vein and Mitral Valve Impingement in Amulet – 

8:40 AM  – 9:00 AM

Panel Discussion

Session VIII  – 

9:00 AM – 9:10 AM

Anatomic Considerations for AtriClip – Mini-Thoracotomy/VATS/Open Approach – 

9:10 AM – 9:30 AM

AtriClip – Recorded Case 

9:30 AM – 9:40 AM

Post Procedural Management of AtriClip – Pericarditis/Anticoagulation/Imaging – 

9:40 AM  – 10:00 AM

Panel Discussion

10:00 AM – 10:20 AM

Break

Session IV Miscellaneous LAA Occlusion Devices

10:20 AM – 10:30 AM

LAmbre – Recorded Case 

10:30 AM – 10:40 AM

WaveCrest Device – Recorded Case

10:40 AM – 10:50 AM

Conforma LAA Occlusion Device

10:00 AM – 10:50 AM

Less Studied LAA Occlusion Devices – An Overview and Relevance (Includes Aegis/Occlutech/Prolipsis/Cardia/Acoredis and More)

11:00 AM – 11:20 AM

Panel Discussion

 

Session X 

11:20 AM – 11:30 AM

WATCHMAN Trials Update 

11:30 AM – 11:40 AM

Left Atrial Appendage Occlusion in Contraindicated Patients 

11:40 AM – 11:50 AM

Amplatzer Cardiac Plug Trials Update – Amulet IDE and More 

11:50 AM – 12:00 PM

AtriClip and Other Surgical Tools – LAAOs III and More – 

12:00 PM – 12:10 PM

WaveCrest Device Trials Update – 

12:10 PM – 12:30 PM

Panel Discussion

12:30 PM- 1:00 PM

Lunch

Session XI Oral Anticoagulants in 2017

1:00 PM – 1:30 PM

LAA Exclusion is a Better Strategy for Stroke Prophylaxis than Oral Anticoagulation in AF Patients — Debate – 

1:30 PM- 1:40 PM

Subclinical Atrial Fibrillation and Stroke – 

1:40 PM- 1:50 PM

What Other Data is Needed in the LAA Space – 

1:50 PM – 2:00 PM

Transitioning LA Exclusion Technology from Clinical Trials to Market Place – Lessons Learned from the Lariat, WATCHMAN and ACP Experience – 

2:00 PM- 2:10 PM

How to Build a Successful LAA Referral Program – 

2:10 PM- 2:30 PM

Panel Discussion

2:30 PM – 2:40 PM

Break

Session XII P

2:40 PM – 2:50 PM

How Do You Manage Patients with Persistent LAA Filling Defect (thrombus)?

2:50 PM – 3:00 PM

Are NOACs Really Superior to Warfarin? The Impact of Compliance and Real-World Issues – 

3:00 PM – 3:10 PM

Will NOACs Alleviate the Need for LAA Occlusion? What Will a NOAC versus LAAO Trial Look Like? – 

3:10 PM – 3:20 PM

Understanding NOACs in the 21st Century – Dual/Triple Therapy and Balancing AF and CAD – 

3:20 PM – 3:30 PM

My Patient Has an LAA Occluder and Had an Embolic CVA with No Evidence of Device Related Thrombus or Carotid Disease – 

3:30 PM – 3:40 PM

Can LAAO Mitigate the Risk of Dementia in Patients with AF?

3:40 PM – 3:50 PM

Role of Reversal Agents in the Management of OAC

3:50 PM – 4:10 PM

Panel Discussion

Session XIII 

4:10 PM – 5:00 PM

My Most Challenging Cases

5:00 PM

Adjourn/Remarks

 

Copyright © ISLAA-KC. All Rights Reserved. Privacy Policy
Site Created by KC Web Specialists, LLC.